Novobeing
PrivateLast Round
Strategic
Dec 3, 2024
Company Overview
Novobeing operates in Healthcare & Life Sciences and is based in Burlington, Massachusetts. Its latest recorded funding round was a Strategic round in December 2024.
Novobeing is a digital health company that provides a therapeutic VR platform to reduce stress, anxiety, and pain.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, AR/VR Experiences, Medical Devices, Patient Engagement
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novobeing Comparables
Compare Novobeing with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Virtual Therapeutics | 85% | |
| TRIPP, Inc. | 84% | |
| Healium | 83% |
For institutional investors. Book with your work email.
Novobeing Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 3, 2024 | ||||
| Accelerator | Apr 30, 2024 | ||||
| Seed | Feb 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novobeing Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Roux Institute | Accelerator |
| Maine Venture Fund | Accelerator |
| ImpactAssets | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 3, 2024
Raised a strategic round with participation from Ted Schilowitz.
- Apr 30, 2024
$50K raised from Roux Institute and others.
For institutional investors. Book with your work email.
Novobeing Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novobeing's valuation, stock price, and market status.
Is Novobeing a public or private company?
Novobeing is a private company.
What is the current stock price of Novobeing?
Novobeing is a private company, so its shares have no public market price. Caplight tracks Novobeing's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novobeing worth (valuation)?
Valuation information for Novobeing is not publicly available.
Can I buy Novobeing stock?
Novobeing shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novobeing's last funding round?
Novobeing's most recent funding round was Strategic on December 3, 2024.
Who are the main investors in Novobeing?
Key investors in Novobeing include Roux Institute, Maine Venture Fund, ImpactAssets.
Will Novobeing IPO soon?
No public IPO plans have been announced for Novobeing.
How can I track Novobeing secondary market activity?
Caplight tracks bids, offers, and trades in Novobeing's shares on secondary markets.